Range
0.05 - 0.05
Vol / Avg.
25K/49.1K
Div / Yield
-
52 Wk
0.04 - 0.2
Mkt Cap
7.1M
Payout Ratio
-
Open
0.05
P/E
-
EPS
-0.01
Shares
136.6M
Outstanding
-
Total Float
-
There is no Press for this Ticker
Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on its novel approach to targeting prominent cancer markers and infectious diseases. Its lead product ImMucin successfully completed a Phase 1/2 clinical trial in multiple myeloma for which it received orphan drug status from the FDA and EMA. The company aims to continue to develop ImMucin, a COVID19 and a tuberculosis vaccine/treatment that has demonstrated promising preliminary results with further preclinical evaluation planned. Additional indications and mAb candidates are under evaluation as immuno-oncology and infectious disease treatments alone and in combination with other treatments.

Related Companies

TickerCompanyChg %Mkt Cap
VXLLFVaxil Bio648.06%7.1M

Vaxil Bio Questions & Anwsers

Q

How do I buy Vaxil Bio (VXLLF) stock?

A

You can purchase shares of Vaxil Bio (OTC: VXLLF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Vaxil Bio's (VXLLF) competitors?

A

There are no as such competitors for Vaxil Bio.

Q

What is the target price for Vaxil Bio (VXLLF) stock?

A

There is no analysis for Vaxil Bio

Q

Current Stock Price for Vaxil Bio (VXLLF)?

A

The stock price for Vaxil Bio (OTC: VXLLF) is $0.0516 last updated Today at 6:34:04 PM.

Q

Does Vaxil Bio (VXLLF) pay a dividend?

A

There are no upcoming dividends for Vaxil Bio.

Q

When is Vaxil Bio (OTC:VXLLF) reporting earnings?

A

Vaxil Bio does not have any upcoming earnings scheduled.

Q

Is Vaxil Bio (VXLLF) going to split?

A

There is no upcoming split for Vaxil Bio.

Q

What sector and industry does Vaxil Bio (VXLLF) operate in?

A

Vaxil Bio is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.